all report title image
  • Published On : Dec 2022
  • Code : CMI5421
  • Industry : Pharmaceutical
  • Pages : 172
  • Formats :

The global pigmentation disorders treatment market was valued at US$ 6,087.0 Mn in 2021 and is forecast to reach a value of US$ 9,678.6 Mn by 2028 at a CAGR of 6.9% between 2022 and 2028. The global pigmentation disorders treatment market is experiencing strong growth due to the rise in prevalence of pigmentation disorders and growing geriatric population across the world. Moreover, rise in demand for safe & effective treatment and increasing awareness among people about pigmentation disorders is expected to boost the growth of the market. However, factors such as high cost associated with treatment and lack of reimbursement policies are expected to hamper growth of the global pigmentation disorders treatment market.

Global Pigmentation Disorders Treatment Market: Regional Insights

Based on geography, the global pigmentation disorders treatment market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period due to the increasing prevalence of pigmentation disorders and growing geriatric population in the region. For instance, geriatric population is prone to some pigmentation disorders or some pigmentation disorders more prevalent in the geriatric population. According to the U.S. Census Bureau (2022 report), over 56 million adults ages 65 and older live in the United States, accounting for about 16.9% of the nation's population. By 2030, it is projected that there will be around 73.1 million older adults. This in turn is driving the market growth.

Europe and Asia Pacific are expected to witness robust growth in the global pigmentation disorders treatment market due to high prevalence of pigmentation disorders and rise in geriatric population in these regions. For instance, pigmentation disorders more prevalent in the geriatric population. Asia and Europe are home to some of the world's oldest populations, those ages 65 and above. As per United Nations Economic and Social Commission for Asia and the Pacific (July 2022 report), there are now 630 million people aged 60 years or over, representing 60 per cent of the world's older persons. By 2050, their number is projected to increase to 1.3 billion.

Figure 1. Global Pigmentation Disorders Treatment Market Share (%), by Region, 2022

Pigmentation Disorders Treatment  | Coherent Market Insights

Global Pigmentation Disorders Treatment Market Drivers:

Rise in prevalence of pigmentation disorders worldwide is expected to augment the growth of the global pigmentation disorders treatment market over the forecast period. For instance, pigmentary disorders, such as melasma, vitiligo, and lentigo, pose significant negative impact on the person's health-related quality of life. Thus, there is a need for safe and effective treatment based on their prevalence and effect on quality of life. The Food and Drug Administration (FDA) has approved approvedruxolitinib (Opzelura) cream for the treatment of non-segmental vitiligo in both adult and pediatric patients 12 years of age and older.

Growing geriatric population worldwide is expected to boost the growth of the global pigmentation disorders treatment market during the forecast period. For instance, the geriatric population is more likely to develop certain pigmentation disorders, as aging skin becomes more avascular and make the skin of elderly more marked by pallor. According to the World Health Organization (WHO), by 2030, 1 in 6 people in the world will be aged 60 years or over, and the world’s population of people aged 60 years and older will double (2.1 billion) by 2050. This in turn is expected to aid in the growth of the global pigmentation disorders treatment market.

Global Pigmentation Disorders Treatment Market Opportunities:

Rise in demand for safe & effective treatment is expected to offer significant growth opportunities for players in the pigmentation disorders treatment market. For instance, in May 2022, Clinuvel Pharmaceuticals announced that a new potential therapy for the pigment loss disorder vitiligo will undergo further studies in North America. The drug afamelanotide, approved by US and European regulators for a rare light intolerance disorder, is being evaluated by Clinuvel Pharmaceuticals as a treatment for vitiligo patients with darker skin types.

Increasing awareness among people about pigmentation disorders is expected to offer significant growth opportunities for players in the pigmentation disorders treatment market. For instance, with the growing awareness among the global population, the demand for safe and effective treatment is also increasing rapidly. Thus, players in the market are focusing on the developing and launching novel treatments in the market. In October 2021, Uniza Group announced the launch of a novel solution for the management of Vitiligo in the Indian market.

CMI table icon

Pigmentation Disorders Treatment Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2021: US$ 6,087.0 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2028
Forecast Period 2022 to 2028 CAGR: 6.9% 2028 Value Projection: US$ 9,678.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type of Disorder: Albinism, Vitiligo, Melasma, Post-Inflammatory Hyperpigmentation (PIH),  and Other Types of Disorders
  • By Treatment Type: Topical Treatment, Dermabrasion, Chemical peels, Laser Treatment, Phototherapy, and Other Treatment Types
Companies covered:

Abbvie Inc. (Allergan Inc.), Episciences Inc., L'ORÉAL SA (SkinCeuticals International), and Pfizer Inc., among others.

Growth Drivers:
  • Rise in prevalence of pigmentation disorders worldwide
  • Growing geriatric population worldwide
Restraints & Challenges:
  • High cost associated with the treatment
  • Lack of reimbursement policies

Global Pigmentation Disorders Treatment Market Trends:

One of the major trends in the pigmentation disorders treatment market is the increasing focus on the development of safe and effective pigmentation disorders treatment. Players in the market are focusing on developing and launching safe and effective treatments in the market due to increase in prevalence of pigmentation disorders and increase in demand for novel treatments. This in turn is expected to continue over the forecast period, driving the market growth.

Moreover, the increasing awareness among people about various dermatological disorders has led to an increase in expenditure on dermatological treatments, which is further associated with rise in the standard of living and per capita income levels across the world. This in turn leads to the rise in the expenditure of dermatological treatments, propelling the growth of the global pigmentation disorders treatment market during the forecast period.

Global Pigmentation Disorders Treatment Market Restraints:

High cost associated with the treatment is expected to hamper growth of the global pigmentation disorders treatment market. For instance, the cost of pigmentation treatment depends on the type of treatment and the number of sittings required to correct the skin. The cost of laser pigmentation treatment in India ranges between Rs 5,000 to 8,000 per session. However, the overall cost varies based on factors, such as the strength of pigmentation, skin type, area of the skin to be treated, and underlying health condition, among others.

Lack of reimbursement policies is expected to hinder growth of the global pigmentation disorders treatment market. For instance, reimbursement is provided for medical expenses and treatment, but in the case of pigmentation disorders and its treatments, it is not covered under any policy. Insurance companies rarely cover these procedures, owing to which the patient has to pay out of pocket. The lack of reimbursement policies poses a challenge to the market.

Figure 2. Global Pigmentation Disorders Treatment Market Share (%), by Type of Disorder, 2022

Pigmentation Disorders Treatment  | Coherent Market Insights

Global Pigmentation Disorders Treatment Market Segmentation:

The global pigmentation disorders treatment market report is segmented into Type of Disorder, Treatment Type, and Geography.

Based on Type of Disorder, the global pigmentation disorders treatment market is segmented into Albinism, Vitiligo, Melasma, Post-Inflammatory Hyperpigmentation (PIH), and Other Types of Disorders. Out of which, Albinism Segment is expected to dominate the pigmentation disorders treatment market over the forecast period and this is attributed to the rise in cases of albinism, a rare group of genetic disorders that cause the skin, hair, or eyes to have little or no color.

Vitiligo Segment is also expected to witness significant growth in the near future and this is owing to the increase in prevalence of pigmentation disorders, such as vitiligo.

Based on Treatment Type, the global pigmentation disorders treatment market is segmented into Topical Treatment, Dermabrasion, Chemical peels, Laser Treatment, Phototherapy, and Other Treatment Types. Out of which, Topical Treatment Segment is expected to dominate the market over the forecast period and this is attributed to the increase in demand for topical treatments.

Dermabrasion Segment is also expected to witness significant growth in the near future and this is due to the increase in prevalence of pigmentation disorders. Dermabrasion is a safe and effective cosmetic skincare procedure. Dermabrasion can re-pigment vitiligo.

Global Pigmentation Disorders Treatment Market: Key Developments

In June 2021, National Organization for Albinism and Hypopigmentation announced a call for proposals focusing on research exclusively related to therapeutics and biomarkers development for all types of albinism with a grant of US$ 100,000.

In September 2020, Adventist Development and Relief Agency’s (ADRA) initiated an Innovation Program of cryosurgery cancer treatment for persons with albinism in Tanzania.

In May 2020, Clinuvel Pharmaceuticals attended a Type C meeting in with the U.S. Food and Drug Administration and global clinical experts in vitiligo to discuss the North American development program for SCENESSE (afamelanotide 16mg) for the treatment of vitiligo.

Global Pigmentation Disorders Treatment Market: Key Companies Insights

The global pigmentation disorders treatment market is highly competitive. This is attributed to the increase in demand for safe and effective treatments, as a result, players in the market are focusing on launching novel treatments in the market.

Some of the key players in the global pigmentation disorders treatment market are Abbvie Inc. (Allergan Inc.), Episciences Inc., L'ORÉAL SA (SkinCeuticals International), and Pfizer Inc.

*Definition: Pigmentation is a skin condition caused by high quantities of melanin, a substance in the body that produces hair, eye, and skin pigmentation. Skin pigmentation disorders affect the color of the skin. Some common types of skin pigmentation disorders include albinism, melasma, vitiligo, and pigment changes from skin damage.  

Pigmentation is a skin condition caused by high quantities of melanin, a substance in the body that produces hair, eye, and skin pigmentation. Skin pigmentation disorders affect the color of the skin. Some common types of skin pigmentation disorders are albinism, melasma, vitiligo, and pigment changes from skin damage. Thus, with the rise in prevalence of pigmentation disorders, demand for safe and effective treatment is also increasing rapidly.

Market Dynamics:

Increase in prevalence of pigmentation disorders, growing geriatric population worldwide, rise in demand for safe and effective treatment, increasing awareness among people about pigmentation disorders, and increase in focus on the development of novel treatments are major factors expected to propel growth of the global pigmentation disorders treatment market.

For instance, in July 2022, the U.S. Food and Drug Administration (USFDA) approved ruxolitinib (Opzelura) cream 1.5 percent as a treatment for the most common form of vitiligo, according to a statement by Incyte, the manufacturer of the drug.

Moreover, in October 2021, Uniza Healthcare announced the launched of a novel treatment for the management of Vitiligo in Indian Market. Vitellus is a novel combination of Greyverse, Melitane, GL 200, & EUK-134 which is an advanced new age solution for management of Vitiligo. Vitellus lotion is a 3 in 1 solution and helps in growth of melamine and works on skin pigmentation, hair follicle pigmentation and also as a super antioxidant.

Key features of the study:

  • This report provides in-depth analysis of the global pigmentation disorders treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global pigmentation disorders treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbvie Inc. (Allergan Inc.), Episciences Inc., L'ORÉAL SA (SkinCeuticals International), and Pfizer Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global pigmentation disorders treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pigmentation disorders treatment market.

Detailed Segmentation:

  • Global Pigmentation Disorders Treatment Market, By Type of Disorder:
    • Albinism
    • Vitiligo
    • Melasma
    • Post-Inflammatory Hyperpigmentation (PIH)
    • Other Types of Disorders
  • Global Pigmentation Disorders Treatment Market, By Treatment Type:
    • Topical Treatment
    • Dermabrasion
    • Chemical peels
    • Laser Treatment
    • Phototherapy
    • Other Treatment Types
  • Global Pigmentation Disorders Treatment Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Abbvie Inc. (Allergan Inc.)
    • Episciences Inc.
    • L'ORÉAL SA (SkinCeuticals International)
    • Pfizer Inc.

Frequently Asked Questions

The global pigmentation disorders treatment market size is estimated to be valued at US$ 6,476.5 Million in 2022 and is expected to exhibit a CAGR of 6.9% between 2022 and 2028.
Rise in prevalence of pigmentation disorders and growing geriatric population worldwide is fueling the market.
The melasma segment is the leading type of disorder segment in the market.
High cost associated with the treatment and lack of reimbursement policies are major factors restraining the market.
Major players operating in the market are Abbvie Inc. (Allergan Inc.), Episciences Inc., L'ORÉAL SA (SkinCeuticals International), and Pfizer Inc.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo